Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis

Explore clinical trials studying Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

291 public trials 23 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis trial results

Completed

Real-World Betaseron Health Economic Outcomes Study for Relapsing Forms of Multiple Sclerosis

NCT01158183

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Many Locations, Alabama, United States
  • Many Locations, California, United States
  • Many Locations, Colorado, United States
  • Many Locations, Florida, United States
View all 27 locations
View Trial Details
Completed

A Study for Patients With Secondary Progressive Multiple Sclerosis

NCT00869726

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • St. Michaels Hospital Toronto, Ontario, Canada
  • Copenhagen University Hospital Copenhagen, Denmark
  • West Tallinn Central Hospital Tallinn, Estonia
  • Terveystalo Turku Kuvantaminen Turku, Finland
View Trial Details
Active, Not Recruiting

Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)

NCT06700343

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • University of South Alabama Mobile, Alabama, United States
  • Clinical Endpoints, LLC Scottsdale, Arizona, United States
  • Profound Research - Neurology Center of Southern California Carlsbad, California, United States
  • Mountain Neurological Research Center Basalt, Colorado, United States
View all 109 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis

NCT03523858

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • MS Center of California Laguna Hills, California, United States
  • SC3 Research Group, Inc Pasadena, California, United States
  • University of California San Francisco San Francisco, California, United States
  • University of South Florida Tampa, Florida, United States
View all 120 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS)

NCT05123703

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • UC San Diego La Jolla, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Hospital Washington D.C., District of Columbia, United States
  • Johns Hopkins Medicine Baltimore, Maryland, United States
View all 71 locations
View Trial Details

Related conditions